Dr. Babu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit Street
Boston, MA 02114
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolFellowship, Neurology, 2015 - 2016
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolFellowship, Neuromuscular Medicine (Neurology), 2015 - 2016
- Cleveland Clinic FoundationResidency, Neurology, 2013 - 2015
- Cleveland Clinic FoundationInternship, Internal Medicine, 2014 - 2014
- Cleveland Clinic FoundationFellowship, Child Neurology, 2011 - 2014
- Cleveland Clinic FoundationResidency, Pediatrics, 2009 - 2011
- University of Maryland School of Public HealthMPH, clinical research, 2006 - 2008
- Bangalore Medical CollegeClass of 2003
Certifications & Licensure
- MA State Medical License 2015 - 2026
- ME State Medical License 2021 - 2026
- NH State Medical License 2022 - 2026
- OH State Medical License 2009 - 2015
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Publications & Presentations
PubMed
- 10 citationsSafety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial.Merit Cudkowicz, Angela Genge, Nicholas J. Maragakis, Susanne Petri, Leonard H. van den Berg
The Lancet. Neurology. 2021-10-01 - 246 citationsTrial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral SclerosisSabrina Paganoni, Eric A. Macklin, Suzanne Hendrix, James D. Berry, Michael A. Elliott
The New England Journal of Medicine. 2020-09-02 - 96 citationsLong-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosisSabrina Paganoni, Suzanne Hendrix, Samuel P. Dickson, Newman Knowlton, Eric A. Macklin
Muscle & Nerve. 2021-01-01
Journal Articles
- Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral SclerosisSabrina Paganoni, Michael A Elliott, Samuel Maiser, Margaret A Owegi, Stephen A Goutman, Carlayne E Jackson, Jeffrey D Rothstein, Edward J Kasarskis, Liberty Jenkins, ..., The New England Journal of Medicine
- Integrated Imaging of [11C]-PBR28 PET, MR Diffusion and Magnetic Resonance Spectroscopy 1H-MRS in Amyotrophic Lateral SclerosisSabrina Paganoni, Nazem Atassi, Suma Babu, ScienceDirect
Abstracts/Posters
- Capecitabine Induced Multifocal Leukoencephalopathy: A Case reportSBabu, LVelander, JVensel-Rundo, American society for Neuroimaging, Las Vegas, Nevada, 1/2013
- Differences in mouth-level nicotine delivery with variation in cigarette smoke pHSBabu, PClark et al, 9 International Joint Conference of SRNT (Society for Research on Nicotine and Tobacco) S, Dublin, Ireland, 4/2009
Press Mentions
- Sean M. Healey & AMG Center for ALS Announces First Participant Dosed in Regimen G of the HEALEY ALS Platform Trial Evaluating DNL343 by Denali TherapeuticsJune 8th, 2023
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: